FORA Capital LLC Has $5.47 Million Holdings in The Clorox Company $CLX

FORA Capital LLC lifted its stake in The Clorox Company (NYSE:CLX) by 234.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,526 shares of the company’s stock after acquiring an additional 31,906 shares during the period. FORA Capital LLC’s holdings in Clorox were worth $5,466,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Headlands Technologies LLC acquired a new stake in Clorox during the second quarter worth about $437,000. CANADA LIFE ASSURANCE Co lifted its position in shares of Clorox by 6.4% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 170,282 shares of the company’s stock worth $20,480,000 after acquiring an additional 10,214 shares during the period. Tower Research Capital LLC TRC grew its holdings in shares of Clorox by 103.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,211 shares of the company’s stock worth $866,000 after purchasing an additional 3,674 shares in the last quarter. MUFG Securities EMEA plc bought a new stake in shares of Clorox during the second quarter valued at approximately $44,000. Finally, Captrust Financial Advisors raised its stake in shares of Clorox by 4.3% in the second quarter. Captrust Financial Advisors now owns 36,565 shares of the company’s stock valued at $4,390,000 after purchasing an additional 1,506 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of recent research reports. Morgan Stanley decreased their price target on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Citigroup decreased their target price on shares of Clorox from $130.00 to $120.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 4th. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. UBS Group set a $119.00 price target on shares of Clorox and gave the stock a “neutral” rating in a research note on Tuesday, November 4th. Finally, Wells Fargo & Company decreased their price objective on Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. One research analyst has rated the stock with a Buy rating, thirteen have issued a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox has an average rating of “Reduce” and a consensus price target of $125.69.

Clorox Price Performance

NYSE:CLX opened at $103.98 on Friday. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The firm has a market cap of $12.68 billion, a PE ratio of 16.32, a price-to-earnings-growth ratio of 0.52 and a beta of 0.57. The Clorox Company has a 12 month low of $98.20 and a 12 month high of $166.35. The company’s 50-day moving average price is $109.89 and its two-hundred day moving average price is $119.22.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the previous year, the firm earned $1.86 earnings per share. The business’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s payout ratio is currently 77.86%.

Insider Activity at Clorox

In related news, Director Pierre R. Breber acquired 4,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was acquired at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.